Clinical evaluation of Siddha medicine elathi chooranam for the management of hypertension

Phase II non randomized open clinical evaluation of Siddha medicine elathi chooranam for the management of Uratha pitha vatham (Hypertension)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037810

Enrollment

Registered

2021-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: ELATHI CHOORANAM: 5gms of ELATHI CHOORANAM is administered twice a day with honey for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Primary hypertension Giddiness Sweating Nausea Headache Fatigue Blood pressure level140/90mmhg

Exclusion criteria

Exclusion criteria: Secondary hypertension Hypertension in pregnancy Hypertension with diabetes mellitus Blood pressure above 180/100

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reducing blood pressure up to 10-20 mmHg systolic and 5-10 mmhg in diastolic levelTimepoint: 48days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactSDinesh kumar

Government Siddha Medical College

sasirekha.siddha@gmail.com9444832728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026